Oclassen Report issue

For profit Phase 2
Founded: San Rafael CA United States (1985)
Status: Acquired by Watson Pharmaceuticals (1996) → now AbbVie (2019)

Organization Overview

First Clinical Trial
1999
NCT00000654
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Oclassen Pharmaceuticals